OncoTherapy Science, Inc. — Investor Relations & Filings
Filings indexed
71
across all filing types
Latest filing
2026-05-19
Regulatory Filings
Country
JP
Japan
Listing
T
4564
OncoTherapy Science, Inc. is a biopharmaceutical company focused on the research and development of novel anti-cancer therapies. The company utilizes cancer-specific gene data and comprehensive cancer genome analysis to discover and develop molecular-targeted drugs, antibody drugs, cancer vaccines, and new immunotherapies. Its key technological focuses include liquid biopsy, neoantigen prediction, and T-cell receptor (TCR) repertoire analysis using next-generation sequencing. The company's primary objective is to develop highly effective cancer treatments with minimal adverse events and side effects for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 臨時報告書 | 2026-05-19 | Japanese | |
| 公認会計士等の異動に関するお知らせ | 2026-05-19 | Japanese | |
| 2026年3月期連結業績と前期実績との差異に関するお知らせ | 2026-05-08 | Japanese | |
| 営業外費用等の発生に関するお知らせ | 2026-05-08 | Japanese | |
| 2026年3月期決算短信〔日本基準〕（連結） | 2026-05-08 | Japanese | |
| 第三者割当による第38回新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ | 2026-05-01 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 46525729 | 臨時報告書 | 2026-05-19 | Japanese | ||
| 46541676 | 公認会計士等の異動に関するお知らせ | 2026-05-19 | Japanese | ||
| 46881777 | 2026年3月期連結業績と前期実績との差異に関するお知らせ | 2026-05-08 | Japanese | ||
| 46881774 | 営業外費用等の発生に関するお知らせ | 2026-05-08 | Japanese | ||
| 46881771 | 2026年3月期決算短信〔日本基準〕（連結） | 2026-05-08 | Japanese | ||
| 46880775 | 第三者割当による第38回新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ | 2026-05-01 | Japanese | ||
| 46877329 | 第三者割当による第38回新株予約権（行使価額修正条項付）の大量行使に関するお知らせ | 2026-04-16 | Japanese | ||
|
2025
8 filings
| |||||
| 8495684 | 有価証券届出書（組込方式） | 2025-11-21 | Japanese | ||
| 8161537 | 確認書 | 2025-11-10 | Japanese | ||
| 8161527 | 半期報告書－第25期(2025/04/01－2026/03/31) | 2025-11-10 | Japanese | ||
| 7247256 | 臨時報告書 | 2025-06-26 | Japanese | ||
| 7253522 | 内部統制報告書－第24期(2024/04/01－2025/03/31) | 2025-06-24 | Japanese | ||
| 7253514 | 確認書 | 2025-06-24 | Japanese | ||
| 7253509 | 有価証券報告書－第24期(2024/04/01－2025/03/31) | 2025-06-24 | Japanese | ||
| 7267779 | 有価証券届出書（組込方式） | 2025-04-10 | Japanese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
OncoTherapy Science, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13345/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13345 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13345 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13345 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13345}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OncoTherapy Science, Inc. (id: 13345)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.